Petra Steinacker
Overview
Explore the profile of Petra Steinacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
2818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abu-Rumeileh S, Scholle L, Mensch A, Grosskopf H, Ratti A, Kolsch A, et al.
Nat Commun
. 2025 Mar;
16(1):2019.
PMID: 40044663
Blood phosphorylated (p)-tau 181 and p-tau 217 have been proposed as accurate biomarkers of Alzheimer's disease (AD) pathology. However, blood p-tau 181 is also elevated in amyotrophic lateral sclerosis (ALS)...
2.
Mravinacova S, Bergstrom S, Olofsson J, de San Jose N, Anderl-Straub S, Diehl-Schmid J, et al.
Sci Rep
. 2025 Jan;
15(1):668.
PMID: 39753643
Accurate diagnosis and monitoring of neurodegenerative diseases require reliable biomarkers. Cerebrospinal fluid (CSF) proteins are promising candidates for reflecting brain pathology; however, their diagnostic utility may be compromised by natural...
3.
Barba L, Vollmuth C, Halbgebauer S, Ungethum K, Hametner C, Essig F, et al.
Eur J Neurol
. 2024 Dec;
32(1):e16581.
PMID: 39714176
Background: We aimed to investigate the prognostic role of β-synuclein in comparison to that of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) for predicting functional outcome after...
4.
Barba L, Gaetani L, Sperandei S, Di Sabatino E, Abu-Rumeileh S, Halbgebauer S, et al.
J Neurol
. 2024 Dec;
272(1):85.
PMID: 39708160
Background: People with multiple sclerosis (PwMS) experience various degrees of cognitive impairment (CI). Synaptic dysfunction may contribute to CI in PwMS but cerebrospinal fluid (CSF) synaptic biomarkers are unexplored in...
5.
de San Jose N, Halbgebauer S, Steinacker P, Anderl-Straub S, Abu-Rumeileh S, Barba L, et al.
Transl Neurodegener
. 2024 Nov;
13(1):57.
PMID: 39614344
No abstract available.
6.
Vidovic M, Lapp H, Weber C, Plitzko L, Seifert M, Steinacker P, et al.
Brain Commun
. 2024 Sep;
6(5):fcae288.
PMID: 39239150
Diagnosis of the fatal neurodegenerative disease amyotrophic lateral sclerosis is challenging. Neurofilaments, indicative of neuronal damage, along with creatine kinase, creatinine, myoglobin, and troponin T, representing muscular damage, have been...
7.
Huper L, Steinacker P, Polyakova M, Mueller K, Godulla J, Herzig S, et al.
Alzheimers Dement
. 2024 Jun;
20(7):4461-4475.
PMID: 38865340
Introduction: Frontotemporal lobar degeneration (FTLD) encompasses behavioral variant frontotemporal dementia (bvFTD), progressive supranuclear palsy, corticobasal syndrome/degeneration, and primary progressive aphasias (PPAs). We cross-validated fluid biomarkers and neuroimaging. Methods: Seven fluid...
8.
Barba L, Bellomo G, Oeckl P, Chiasserini D, Gaetani L, Torrigiani E, et al.
J Neurol Sci
. 2024 Jun;
462:123059.
PMID: 38850771
Background: VGF and neuroserpin are neurosecretory proteins involved in the pathophysiology of neurodegenerative diseases. We aimed to evaluate their cerebrospinal fluid (CSF) concentrations in patients with Alzheimer's disease (AD) and...
9.
Swift I, Rademakers R, Finch N, Baker M, Ghidoni R, Benussi L, et al.
Alzheimers Res Ther
. 2024 Mar;
16(1):66.
PMID: 38539243
Background: Pathogenic heterozygous mutations in the progranulin gene (GRN) are a key cause of frontotemporal dementia (FTD), leading to significantly reduced biofluid concentrations of the progranulin protein (PGRN). This has...
10.
Vollmuth C, Fiessler C, Montellano F, Kollikowski A, Essig F, Oeckl P, et al.
Eur Stroke J
. 2024 Feb;
9(3):751-762.
PMID: 38400734
Introduction: Blood-based biomarkers may improve prediction of functional outcome in patients with acute ischemic stroke. The role of neurofilament light chain (NfL) and glial fibrillary acidic (GFAP) as potential biomarkers...